Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Jan 11

PMID 31921137

Citations 134

Authors

Sonal Patel

Aftab Alam

Richa Pant

Samit Chattopadhyay

Affiliations

Soon will be listed here.

Abstract

Wnt signaling is one of the central mechanisms regulating tissue morphogenesis during embryogenesis and repair. The pivot of this signaling cascade is the Wnt ligand, which binds to receptors belonging to the Frizzled family or the ROR1/ROR2 and RYK family. This interaction governs the downstream signaling cascade (canonical/non-canonical), ultimately extending its effect on the cellular cytoskeleton, transcriptional control of proliferation and differentiation, and organelle dynamics. Anomalous Wnt signaling has been associated with several cancers, the most prominent ones being colorectal, breast, lung, oral, cervical, and hematopoietic malignancies. It extends its effect on tumorigenesis by modulating the tumor microenvironment via fine crosstalk between transformed cells and infiltrating immune cells, such as leukocytes. This review is an attempt to highlight the latest developments in the understanding of Wnt signaling in the context of tumors and their microenvironment. A dynamic process known as immunoediting governs the fate of tumor progression based on the correlation of various signaling pathways in the tumor microenvironment and immune cells. Cancer cells also undergo a series of mutations in the tumor suppressor gene, which favors tumorigenesis. Wnt signaling, and its crosstalk with various immune cells, has both negative as well as positive effects on tumor progression. On one hand, it helps in the maintenance and renewal of the leucocytes. On the other hand, it promotes immune tolerance, limiting the antitumor response. Wnt signaling also plays a role in epithelial-mesenchymal transition (EMT), thereby promoting the maintenance of Cancer Stem Cells (CSCs). Furthermore, we have summarized the ongoing strategies used to target aberrant Wnt signaling as a novel therapeutic intervention to combat various cancers and their limitations.

Citing Articles

L. Extract Inhibits Colorectal Cancer Tumor Growth by Modulating Cell Apoptosis and Autophagy.

Tsai M, Chen C, Chen C, Lee M, Wu L, Hsu Y Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996849 PMC: 11854706. DOI: 10.3390/cimb47020128.

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Tufail M, Jiang C, Li N Mil Med Res. 2025; 12(1):7.

PMID: 39934876 PMC: 11812268. DOI: 10.1186/s40779-025-00595-2.

Impact of cell plasticity on prostate tumor heterogeneity and therapeutic response.

Archer M, Lin K, Kolanukuduru K, Zhang J, Ben-David R, Kotula L Am J Clin Exp Urol. 2025; 12(6):331-351.

PMID: 39839748 PMC: 11744350. DOI: 10.62347/YFRP8901.

NKD2 as a Mediator of IFIX Antioncogene-Induced Wnt Signalling and Epithelial-Mesenchymal Transition in Human OSCC.

Wang S, Fan H, Bai J J Cell Mol Med. 2025; 29(2):e70342.

PMID: 39833105 PMC: 11745820. DOI: 10.1111/jcmm.70342.

Secreted Frizzled-Related Protein 1a regulates hematopoietic development in a dose-dependent manner.

Ide A, Carpenter K, Elaswad M, Opria K, Marcellin K, Gilliland C bioRxiv. 2025; .

PMID: 39829913 PMC: 11741364. DOI: 10.1101/2025.01.10.632371.

References

Osada M, Jardine L, Misir R, Andl T, Millar S, Pezzano M . DKK1 mediated inhibition of Wnt signaling in postnatal mice leads to loss of TEC progenitors and thymic degeneration. PLoS One. 2010; 5(2):e9062. PMC: 2817005. DOI: 10.1371/journal.pone.0009062. View

Valencia J, Hernandez-Lopez C, Martinez V, Hidalgo L, Zapata A, Vicente A . Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features. J Immunol. 2011; 187(8):4129-39. DOI: 10.4049/jimmunol.1101243. View

Swafford D, Manicassamy S . Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance. Discov Med. 2015; 19(105):303-10. PMC: 4513356. View

Jiang J, Lan C, Li L, Yang D, Xia X, Liao Q . A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(10):3459-3467. DOI: 10.1016/j.bbadis.2018.07.035. View

Ojalvo L, Whittaker C, Condeelis J, Pollard J . Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol. 2009; 184(2):702-12. PMC: 3226722. DOI: 10.4049/jimmunol.0902360. View

Ormestad M, Astorga J, Landgren H, Wang T, Johansson B, Miura N . Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development. 2006; 133(5):833-43. DOI: 10.1242/dev.02252. View

Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

Schott A, Landis M, Dontu G, Griffith K, Layman R, Krop I . Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res. 2013; 19(6):1512-24. PMC: 3602220. DOI: 10.1158/1078-0432.CCR-11-3326. View

Marvel D, Gabrilovich D . Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015; 125(9):3356-64. PMC: 4588239. DOI: 10.1172/JCI80005. View

10.

Lee Y, Chen M, Lee J, Zhang J, Lin S, Fu T . Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019; 364(6441). PMC: 7081834. DOI: 10.1126/science.aau0159. View

11.

Marcus A, Gowen B, Thompson T, Iannello A, Ardolino M, Deng W . Recognition of tumors by the innate immune system and natural killer cells. Adv Immunol. 2014; 122:91-128. PMC: 4228931. DOI: 10.1016/B978-0-12-800267-4.00003-1. View

12.

Clevers H . Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127(3):469-80. DOI: 10.1016/j.cell.2006.10.018. View

13.

Gordon M, Nusse R . Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006; 281(32):22429-33. DOI: 10.1074/jbc.R600015200. View

14.

Steding C, Wu S, Zhang Y, Jeng M, Elzey B, Kao C . The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis. Immunology. 2011; 133(2):221-38. PMC: 3088984. DOI: 10.1111/j.1365-2567.2011.03429.x. View

15.

Baykal C, Ayhan A, Al A, Yuce K, Ayhan A . Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol Oncol. 2003; 88(2):123-9. DOI: 10.1016/s0090-8258(02)00073-2. View

16.

Gattinoni L, Ji Y, Restifo N . Wnt/beta-catenin signaling in T-cell immunity and cancer immunotherapy. Clin Cancer Res. 2010; 16(19):4695-701. PMC: 3393131. DOI: 10.1158/1078-0432.CCR-10-0356. View

17.

Ho S, Keller T . The use of porcupine inhibitors to target Wnt-driven cancers. Bioorg Med Chem Lett. 2015; 25(23):5472-6. DOI: 10.1016/j.bmcl.2015.10.032. View

18.

Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z . A mechanism for Wnt coreceptor activation. Mol Cell. 2004; 13(1):149-56. DOI: 10.1016/s1097-2765(03)00484-2. View

19.

Levanon D, Goldstein R, Bernstein Y, Tang H, Goldenberg D, Stifani S . Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A. 1998; 95(20):11590-5. PMC: 21685. DOI: 10.1073/pnas.95.20.11590. View

20.

MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View